Mirati Therapeutics, Inc.
MRTX · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $259 | $130 | $242 | $235 |
| Short-Term Investments | $718 | $650 | $660 | $849 |
| Receivables | $20 | $16 | $6 | $1 |
| Inventory | $20 | $9 | $4 | $3 |
| Other Curr. Assets | $19 | $15 | $27 | $21 |
| Total Curr. Assets | $1,036 | $819 | $939 | $1,109 |
| Property Plant & Equip (Net) | $51 | $52 | $53 | $54 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $14 | $14 | $15 | $15 |
| Long-Term Investments | $4 | $5 | $3 | $3 |
| Tax Assets | $24 | $24 | $0 | $0 |
| Other NC Assets | $1 | $1 | $23 | $22 |
| Total NC Assets | $94 | $96 | $94 | $94 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,130 | $915 | $1,034 | $1,203 |
| Liabilities | – | – | – | – |
| Payables | $38 | $33 | $22 | $39 |
| Short-Term Debt | $8 | $8 | $8 | $8 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | -$8 | -$8 | $0 | $0 |
| Other Curr. Liab. | $91 | $100 | $94 | $113 |
| Total Curr. Liab. | $137 | $140 | $125 | $159 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $46 | $46 | $47 | $47 |
| Total NC Liab. | $46 | $46 | $47 | $47 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $183 | $186 | $171 | $206 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,976 | -$2,814 | -$2,637 | -$2,453 |
| AOCI | -$2 | -$2 | -$2 | -$4 |
| Other Equity | $3,924 | $3,545 | $3,502 | $3,453 |
| Total Equity | $946 | $729 | $863 | $997 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,130 | $915 | $1,034 | $1,203 |
| Net Debt | -$251 | -$122 | -$234 | -$227 |